Add time:07/22/2019         Source:sciencedirect.com

In an effort to develop novel inhibitors of receptor for advanced glycation end products (RAGE) for the treatment of Alzheimer's disease, a series of pyrazole-5-carboxamides were designed, synthesized and biologically evaluated. Analyses of the extensive structure–activity relationship (SAR) led us to identify a 4-fluorophenoxy analog (40) that exhibited improved in vitro RAGE inhibitory activity and more favorable aqueous solubility than the parent 2-aminopyrimidine, 1. Surface plasmon resonance (SPR) and molecular docking study strongly supported the RAGE inhibitory activity of pyrazole-5-carboxamides. The brain Aβ-lowering effect of 40 is also described.

We also recommend Trading Suppliers and Manufacturers of 5-[3-(Diethylamino)propoxy]-3-methyl-1-phenyl-1H-pyrazole (cas 15083-54-2). Pls Click Website Link as below: cas 15083-54-2 suppliers